Print this page

Naunton, Dr Mark

Dr Mark Naunton

Associate Professor and Head of Discipline, Pharmacy
Faculty of Health

Bldg, Floor & Room: 12, D56
Telephone: (02) 6201 2462
Facsimile: (02) 6201 5727
Mark.Naunton@canberra.edu.au

Biography

Mark is the Head of Pharmacy Discipline. Mark's career in pharmacy includes: academic, locum, managing, and consultant pharmacist in Tasmania, Northern Territory, and the Australian Capital Territory. Mark has international research experience and was a post-doctoral fellow at the University of Groningen, The Netherlands. Mark has held/holds several medication review contracts with Aged Care Facilities in the NT and ACT. Mark is a member of the editorial board for Journal of Clinical Pharmacy and Therapeutics, a leading international journal in pharmacy and clinical pharmacology. Mark is an assessor for the Australian Research Council and reviewer, inter alia, for the Australian Medicines Handbook and Australian Pharmaceutical Formulary and Handbook. 

Areas of Teaching

  • Applied Therapeutics
  • Research Planning
  • Research Project
  • Pharmacy Practice
  • Quality Use of Medicines
  • Pharmaceutics (dispensing)

Research Interests

  • Clinical Pharmacy
  • Aged Care
  • Drug Utilization and Medication Safety
  • Pharmacoeconomics
  • Pharmacoepidemiology
  • Health Literacy
  • Pharmacy Education
  • Medication Adherence
  • Infectious Diseases
  • Therapeutic Drug Monitoring

Qualifications Obtained

  • Bachelor of Pharmacy (Hons I), PhD, University of Tasmania

Professional Qualifications and Memberships

  • Registered Pharmacist Australian Health Practitioner Registration Agency (AHPRA)
  • Member and Accredited Pharmacist with Australian Association of Consultant Pharmacy (AACP) 
  • Member, Pharmaceutical Society of Australia (PSA) 
  • Member, Society of Hospital Pharmacists Australia (SHPA)
  • Member, Medicare Local Australian Capital Territory
  • Member, Australian Association of Gerontology
  • Scientific Board Member, Foundation for Angleman Syndrome Therapeutics (FAST)
  • Member, Glaucoma Australia Pharmacy Liaison Committee

Recent Publications

Professional and Research Publications

  • Jackson S, Naunton M. Optimising medicine administration in patients with swallowing difficulties. Aust Pharm 2017; 36(1): 28-31.
  • Naunton M, Deeks L. Ceasing sertraline: can be an anxious experience. Aust Pharm 2017; 26(1): 54-57.
  • Kellett J, Kyle G, Itsiopoulos C, Naunton M. Nutrition Screening Practices amongst Australian Residential Aged Care Facilities. J Nutr Health Aging. 2016;20(10):1040-1044.
  • Kellett J, Kyle G, Itsiopoulos C, Naunton M, Luff N.  Malnutrition: the importance of identification, documentation and coding in the acute care setting. J Nut Metab 2016 (in press)
  • Naunton M, Jackson S. Deprescribing topical agents for glaucoma. Aust Pharm 2016; 35(9) 28-29.
  • Naunton M, Nor K, Bartholomaeus A, Thomas J, Kosari S. Case report of a medication error: In the eye of the beholder. Medicine (Baltimore). 2016 Jul;95(28):e4186
  • Thomas J, Walton B, Carson C, Peterson G, Naunton M, Davey R, Spelman T, Dettwiller P, Kyle G, Cooper G. Therapeutic Potential of Tea Tree oil for Scabies: A Review, The American Journal of Tropical Medicine and Hygiene 2016 94(2):258-66.
  • Williams CR, Webb CE, Orre S, Naunton M, Thomas, J. Can kunzea oil (Kunzea ambigua) control head lice (Pediculus humanus capitis)?, Parasitology open, (in press).
  • Soriano C, Weschler D, White A, Goldberg, I, Pollard G, Naunton M. "An evaluation of Australian Pharmacists' knowledge of Glaucoma: Effectiveness of Continuous Professional Development education events". Pharmacy Education 2016; 16: 42-47.
  • Kosari S, Naunton M. Sleep Disturbances and Nightmares in a Patient Treated with Prazosin. J Clin Sleep Med. 2016 Apr 15;12(4):631-2. doi: 10.5664/jcsm.5708.
  • Kellett J, Kyle G, itsiopoulos C, Naunton M, Bacon R. Malnutrition Prevalence in Aged Care Residents: A Pilot Study. Topics in Clin Nutrition. 2015;30(3):197-82.
  • Thomas J, Peterson GM, Walton SF, Carson CF, Naunton M, Baby KE. Scabies: an ancient global disease with a need for new therapies. BMC Infect Dis. 2015 Jul 1;15:250. doi: 10.1186/s12879-015-0983-z
  • Naunton M, Gardiner H, Kyle G. Look-alike, sound-alike medication errors: a novel case concerning a Slow-Na, Slow-K prescribing error. Int Med Case Rep J. 2015 Feb 16;8:51-3. doi: 10.2147/IMCRJ.S78637.
  • Waddington F, Naunton M, Kyle G, Thomas, J, Cooper G, Waddington A. A Systematic Review of The Research Regarding Community Pharmacist Knowledge of Dietary Supplements. Int J Clin Pharm. 2015 Jun;37(3):439-446
  • Naunton M. Re: Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines. BMJ 12 March 2015 (letter)
  • Naunton M. Summer can be a bitter sweet time? Australian Pharmacist 2015 34(1):22-23 [invited feature article]
  • Robaei D, Watson S, Naunton M, Mercovich N. Seeing Red: Over-the-Counter Chloramphenicol. Clin Experiment Ophthalmol. 2015 Mar;43(2):99-100. doi: 10.1111/ceo.12497.
  • McDerby N, Robaei D, Watson S, Naunton M. Inappropriate use of chloramphenicol results in vision loss Clin Experiment Ophthalmol. 2015 Mar;43(2):192-3. doi: 10.1111/ceo.12465.
  • Mutie M, Cooper G, Kyle G, Naunton M , Zwar N Travelling with medications and medical equipment across international borders. Travel Med Infect Dis 2014 Aug 6. pii: S1477-8939(14)00133-1. doi: 10.1016/j.tmaid.2014.07.007.
  • Waddington F, Naunton M, Kyle G. Nutritional intake of Opioid Replacement Therapy Patients in Community Pharmacies: A Pilot Study.   Nutrition & Dietetics  2014 (in press)
  • Waddington F, Naunton M, Thomas J. Analgesic Nephropathy: are you kidney-ing me? Int Med Case Rep J 2014 Dec 15;8:1-5. doi: 10.2147/IMCRJ.S71471.
  • Kellett J, Kyle G, Itsiopoulos C, Naunton M, Bacon R, Costello L. 2014. Malnutrition prevalence and nutrition issues in five Australian Residential Aged Care Facilities. In Luszcz M and Feist H (Eds) Making Research Matter: Program and Proceedings of the 13th National Conference of Emerging Researchers in Ageing, pp72-75. Adelaide, 24-25 November, 2014.
  • Naunton M, Kyle G, Owoka F, Naunton-Boom K. Pharmacist review prevents evolving metformin-associated lactic acidosis (MALA). J Clin Pharm Ther. 2014 Oct;39(5):567-70. doi: 10.1111/jcpt.12187.
  • Peterson, G.M, &  Naunton M. Re: Children living near fast food outlets in England are more likely to be overweight, study shows. BMJ 2014;348:g1557.  doi: http://dx.doi.org/10.1136/bmj.g1557
  • Mutie M, Naunton M, Cooper G, Kyle G, Zwar N. Role of pharmacists in collaborative care of travellers with chronic conditions. Travel Med Infect Dis. 2014 May-Jun;12(3):286-7
  • Waddington F, Naunton M, Kyle G. Statins: a Catalyst for non-adherence. Aust Pharm 2014; 33(3):62-6  
  • Mutie M, Cooper GM, Kyle G, Naunton M. A travel health service road map for pharmacists. Aust Pharm 2014;33(3):68-71Mutie M, Cooper G, Kyle G, Naunton M, Zwar N. Travelling with medications and medical equipment across international borders. Travel Medicine and Infectious Disease 2014 (in press)
  • Naunton M, Kyle GJ, Owoka F, Naunton-Boom K. Pharmacist review prevents evolving metformin-associated lactic acidosis. J Clin Pharm Ther. 2014;Early View (online). DoI 10.1111/jcpt.12187
  • Mutie M, Naunton M, Cooper G, Kyle G, Zwar N. Role of pharmacists in collaborative care of travellers with chronic conditions. Travel Med Infect Dis. 2014 May-Jun;12(3):286-7
  • Waddington F, Naunton M, Kyle G. Statins: a Catalyst for non-adherence. Aust Pharm 2014;  33(3):62-6
  • Mutie M, Cooper GM, Kyle G, Naunton M. A travel health service road map for pharmacists. Aust Pharm 2014;33(3):68-71
  • Peterson, G. M., &  Naunton, M. (2014). Re: Children living near fast food outlets in England are more likely to be overweight, study shows. BMJ 2014;348:g1557.
  • Naunton M. Statin-induced myopathy: Innocent until proven otherwise? Aust Pharm 2013; 32(11):66-71
  • Naunton M, Goldberg I. Glaucoma: Management is in the eye of the beholder. Aust Pharm 2013; 32(9):66-69
  • Deeks L, Naunton M, Currie MJ, Bowden FJ. Topical ivermectin 0.5% for treatment of head lice. Ann Pharmacother. 2013 Sep;47(9):1161-7
  • McDerby N, Kyle G, Naunton M. Safe to crush? A pilot study into solid dosage form modification in aged care. Australasian Journal on Ageing 2013 (in press). DOI: 10.1111/ajag.12037
  • Sutcliff E, Naunton M, Kyle G. Managing Gout. Aust Pharm 2013; 32(1):62-7
  • Naunton M, Merrilees L. Evidence in patient care: Venous thromboembolism prophylaxis. Aust Pharm 2012; 31(5) :392-96
  • Deeks L, Cooper G, Naunton M. Public health screening in the pharmacy: a focus on chlamydia. Aust Pharm 2012; 31(3):210-16.
  • De Zylva JB, Naunton M, Szabo F, Dettwiller P. Adherence to Prophylaxis Guidelines in Patients that Develop Symptomatic Venous Thromboembolism. J Pharm Pract Res 2012; 42(1):37-42.
  • Naunton M. Post-hospital Discharge Home Medication Review: Proof of Concept (n=1). Aust Pharm 2011; 30(12):1026-32.
  • Naunton M. The Easter bunny and the chocolate conspiracy. Med J Aust 2011; 194(12):672
  • Peterson GM, Naunton M. Safety of Ibuprofen vs. paracetamol. Br J Clin Pharmacol 2011;71(6):964
  • Duyvendak M, Naunton M, van Roon EN, Brouwers JRBJ. Doctors' beliefs and knowledge on corticosteroid-induced osteoporosis: identifying barriers to improve prevention. J Clin Pharm Ther. 2011 Jun;36(3):356-66
  • Peterson GM, Naunton M, Tichelaar LK, Gennari L. Lasofoxifene: Selective Estrogen Receptor Modulator for the Prevention and Treatment of Postmenopausal Osteoporosis. Ann Pharmacother 2011 Apr;45(4):499-509
  • Peterson GM, Tan SI, Jackson SL, Naunton M. Violence in community pharmacy in Australia: incidence and implications. Int J Clin Pharm. 2011 Apr;33(2):264-72
  • Naunton M. The case for ceasing hormone therapy and the benefits of collaborative RMMRs. Australian Pharmacist 2011; 30(1):63-66
  • Naunton M. An endothelin antagonist for resistant hypertension. The Lancet, 2010 375(9715):636
  • Naunton M. Medication review – Weight loss, diabetic control and Turkish bread … just another brick in the wall. Australian Pharmacist 2010; 29(4): 326-30
  • Luinstra M, Naunton M, Peterson GM, Bereznicki L. PPI use in patients commenced on clopidogrel: A retrospective cross-sectional evaluation. J Clin Pharm Ther 2010; 35:213-17
  • Naunton M. Medication Review: Angelman syndrome and withdrawal from antiepileptics. Australian Pharmacist 2009;28(12): 1043-46
  • Luinstra M, Naunton M, Peterson GM, Bereznicki L. Prescribing patterns of clopidogrel and concordance with the Pharmaceutical Benefit Scheme at two major Australian hospitals. J Pharm Pract Res 2009; 39(4):265-68
  • Naunton M. Post-hospital Discharge: Perfect Time for Home Medication Review. Australian Pharmacist 2009; 28(4):312-15
  • Duyvendak M, Naunton M, van Roon EN, Bruyn GAW, Brouwers JRBJ. Systematic Review of Trends in Prophylaxis of Corticosteroid-Induced Osteoporosis: The need for standard audit. Osteoporos Int 2008 Oct;19(10):1379-94
  • Peterson GM, Naunton M. Asthma in the elderly. Australian Pharmacist 2008;27(5):382-86.
  • Naunton M, Peterson GM. Clinical Update: Epilepsy. Australian Pharmacist 2007; 26(10): 816-21
  • Naunton M, Duyvendak M, Brouwers JR. Dose conversion: opportunity for error. Am J Med. 2007 Nov;120(11):e1.
  • Naunton M. Stroke prophylaxis in patients with atrial fibrillation: what can we do about it? Eur Heart J. 2007 May;28(9):1172-3
  • Duyvendak M, Naunton M, Atthobari J, Van den Berg PB, Brouwers JR. Corticosteroid-induced osteoporosis prevention: Longitudinal practice patterns in The Netherlands 2001-2005, Osteoporos Int, 2007 Oct;18(10):1429-33.
  • Ivanovic N, Naunton M, Beinema M, Brouwers JR, Postma MJ.Thromboprophylaxis in total hip-replacement surgery in Europe: acenocoumarol, fondaparinux, dabigatran and rivaroxaban. Expert Rev Pharmacoecon Outcomes Res. 2007 Feb;7(1):49-58
  • Naunton M, Doggrell S. I must see the pharmacist: asthma devices. Australian Pharmacist 2007; 26(4): 302-04.
  • Naunton M. I must see the pharmacist: osteoporosis. Australian Pharmacist, 2007;26(2):138-42.
  • Peterson GM, Jackson SJ, Naunton M. Home medicines review in the elderly: most effective if performed and reported in a timely manner Australian Pharmacist 2006; 25(11): 860-63.
  • Peterson GM, Jackson SJ, Naunton M, Gillman K. Delirious dangers of the deadly nightshade: beware of anticholinergics in the elderly Australian Pharmacist 2006; 25(11): 882-84.
  • Naunton M, Gillman KG. Pharmacy students and BIG pharma. Australian Pharmacist 2006 25(8): 585-86.
  • Naunton M, Peterson GM, Jackson SJ. Constipation in the elderly: can we achieve movement with evidence-based recommendations? Australian Pharmacist 2006; 25(7): 564-69.
  • Naunton M, Peterson GM, Jones G. Under-use of bisphosphonates in rural elderly women who have sustained fractures Australian Pharmacist Aust J Rural Health. 2006 Dec;14(6):286.
  • Naunton M, Peterson GM. Serotonin toxicity in the elderly. Australian Pharmacist 2006;25(5):406-09.
  • Naunton M, Peterson GM. I must see the pharmacist – vertebral fractures. Australian Pharmacist 2006;25(4):296-301.
  • Naunton M. Is the increase in osteoporosis prevention a result of the audit? Clinical Neurology and Neurosurgery 2006 Oct;108(7):718-9.
  • Naunton, M, Al Hadithy A, Brouwers JRBJ, Archer DF. Estradiol gel – Review of the Pharmacology, Pharmacokinetics, Efficacy and Safety in Menopausal Women. Menopause 2006 May-Jun;13(3):517-27.
  • Naunton M. Near drowning--the importance of basic first aid. Croat Med J 2006 Feb;47(1):187-8.
  • Naunton M, Duyvendak M., Peterson G.M., Brouwers J.R.B.J. Practice patterns in glucocorticosteroid-induced osteoporosis. Osteoporos Int. 2006; 2006;17(4):634-5.
  • Naunton M, Peterson GM, Jones G. Pharmacist-provided quantitative heel ultrasound screening for rural women at risk of osteoporosis. Ann Pharmacother. 2006 Jan;40(1):38-44.
  • Naunton M, Duyvendak M, Peterson GM, Brouwers JR. Comments on Glintborg et al.'s drug-drug interactions study (EJCP 2005; 61: 675-681). Eur J Clin Pharmacol 2006 Jan 12:1-2.
  • Naunton M, Duyvendak M. Underuse of antiplatelets and inappropriate use. Eur J Clin Pharmacol 2006 Jan;62(1):81-2.
  • Naunton M, Jackson S. Fosamax, Celebrex or Panamax? Australian Pharmacist 2006 25 (1): 6.
  • Peterson GM, Naunton M, Jackson SL. Analgesia in the elderly: should not be a painful experience. Australian Pharmacist 2006; 25(1): 52-5.
  • Naunton M, Peterson GM. Don't forget the evidence: Alzheimer's disease. Australian Pharmacist 2005; 24(11): 878-81.
  • Duyvendak M, Naunton M, Peterson G.M., Brouwers J.R.B.J., A pilot study on doctors' beliefs and knowledge on corticosteroid-induced osteoporosis prevention: identifying barriers to improve practice. Eur J Hosp Pharm Science, 2005;5:114-20.
  • Duyvendak M, Naunton M, Kingma BJ, Brouwers JR. Thalidomide-associated thrombocytopenia. Ann Pharmacother 2005;39(11):1936-9.
  • Peterson GM, Naunton M. Valproate: a simple chemical with so much to offer. J Clin Pharm Ther 2005;30(5):417-21.
  • Boersma C, Klok RM, Bos JM, Naunton M, van den Berg PB, de Jong-van den Berg LT, Postma MJ. Drug costs developments after patent expiry of enalapril, fluoxetine and ranitidine: a study conducted for the Netherlands. Appl Health Econ Health Policy 2005;4(3):191-6.
  • Al Hadithy AFY, Naunton M, Brouwers JRBJ. Thiopurines for inflammatory bowel disease: role of pharmacogenetics. J Pharm Pract Res 2005; 35(3): 213-15.
  • Naunton M, Peterson GM, Bereznicki L, Jackson SL. The enigma of aspirin in primary prevention. Australian Pharmacist 24 (9) 718-722 (2005).
  • Naunton M, Peterson GM. Author response. Australian Pharmacist 2005 24(8): 581.
  • Naunton M, Peterson GM. The " D"ilemma : ensuring the elderly fall in love with vitamin D. Australian Pharmacist 2005;24(7): 563-66.
  • Naunton M , Peterson GM. Newly diagnosed asthma in a child. Australian Pharmacist 2005;24(6): 448-51.
  • Naunton M, Peterson GM, Jones G. The role of pharmacy in screening for osteoporosis Australian Pharmacist 2005; 24(6): 484-87.
  • Naunton M, Jackson SL, Digoxin/Diamox. Australian Pharmacist 2005; 24(3): 183.

(Co)Author of Book/Report

  • Cooper GM, Naunton M. PSA Self Care User Review. Report of Findings and Recommendations to Pharmaceutical Society of Australia. August 2011 ISBN 978-1-74088-353-5: 1-33.
  • Daniels A (ed). Hughes J, Tenni P, Peterson GM (Lead authors), Jackson SJ, Naunton M (contributing authors). The Australian Pharmacist Aged Care Primer. The Pharmaceutical Society of Australia, 2007. ISBN 9780908185887: 1-380.
  • Naunton M, Osteoporosis, Pharmaceutical Society of Australia, Sydney (March 2006).
  • Jackson SL, Naunton M, Peterson GM. Compliance, Pharmaceutical Society of Australia, Sydney (June 2006).

Congress publications

  • Hruz J, Naunton M. Health Literacy of Antihypertensive Users and Readability of Written Health Information. Society of Hospital Pharmacists of Australia, Federal Conference, November 1-4, 2012, Canberra, ACT, Australia (accepted).
  • Duyvendak M, Naunton M, van Roon EN, Bruyn GAW, Brouwers JRBJ. Multifaceted intervention by pharmacists: the effect on prevention of corticosteroid-induced osteoporosis (CIOP). Australasian Pharmaceutical Science Association (APSA) December 9-11, 2009, Hobart, Tasmania.
  • Surti H, Rumble R, Naunton M, Dettwiller P. Factors affecting the use of medications in older indigenous and non-indigenous adults. Society of Hospital Pharmacists of Australia, Federal Conference, November 5-8, 2009, Perth, Western Australia
  • Luinstra M, Naunton M, Peterson GM, Bereznicki L. PPI use in patients commenced on clopidogrel: A retrospective cross-sectional evaluation. Society of Hospital Pharmacists of Australia, Federal Conference, November 5-8, 2009, Perth, Western Australia.
  • Duyvendak M, Naunton M, Roon van EN, Brouwers JRBJ. Corticosteroid-induced osteoporosis prevention: Longitudinal practice patterns in The Netherlands 2001-2005. European Congress of Clinical Pharmacology 29th Aug-1st Sept 2007, Amsterdam, The Netherlands
  • Duyvendak M, Naunton M, Schiere S, Brouwers J.R.B.J. Prevention of corticosteroid-induced osteoporosis: practice patterns in the Netherlands. 35th European Symposium on Clinical Pharmacy 18-21 October 2006 Vienna, Austria.
  • Naunton M, Jackson SJ, Duyvendak M. Identification and resolution of drug related problems in Tasmanian aged-care facilities. 35th European Symposium on Clinical Pharmacy 18-21 October 2006 Vienna, Austria.
  • Duyvendak M, Naunton M, Schiere S, Brouwers J.R.B.J, Need for clinical pharmacy services in orthopaedic patients in The Netherlands, 40th, ASHP midyear clinical meeting and exhibition Las Vegas, 7 December 2005.
  • Taxis K, Naunton M Toering DJ, Shah R, Patient profiles as a learning tool for the practice of pharmaceutical care. 34th European Symposium on Clinical Pharmacy 26 -29 October 2005 Amsterdam, The Netherlands.
  • Naunton M, GM Peterson GM, Jones G. Evaluation of a pharmacist performing osteoporosis screening in rural pharmacies using quantitative heel ultrasound (QUS). Australian New Zealand Bone Mineral Society Conference August 18-20 2004, Hunter Valley, NSW, Australia.
  • Duyvendak M, Naunton M, Herder A, Klopotowska ., Schiere S, Brouwers JRBJ, Perioperative pharmacotherapeutic risk management in orthopedic patients. Dutch Society of Anaesthesiology, 30 September 2005, Amsterdam, The Netherlands.

Grants

  • Improving antibiotic use in the community setting: An Evidence Based Review of Strategies Targeting Health Professionals. NPS Medicine – Wise. $30,000
  • Evaluation of an environmentally friendly formulation for the management of Pediculosis (head lice) in humans. Project funded by, University of Canberra, Faculty of Health Science: $9,700
  • Randomised controlled trial of nitazoxanide for acute gastroenteritis in Australian Indigenous children. NHMRC. ($1.2M)
  • Corticosteroid-induced Osteoporosis. Royal Hobart Hospital Research Foundation($5,000)
  • Review on Topical Ivermectin ($5,000), University of Canberra
  • Merck Sharp & Dohme unrestricted grant for research on corticosteroid osteoporosis (€54,000)
  • DFZ (De Friesland Zorgverzekeraar [Health Insurance Company]) grant for research on corticosteroid-induced osteoporosis (€50.000)
  • Dutch Society of Pharmacists [Nederlandse Maatschappij ter bevordering van de Pharmacy (KNMP)] grant for research on corticosteroid-induced osteoporosis (€50.000)
  • NVZA (Dutch Society of Hospital Pharmacists) grant for research on perioperative drug management (€50.000)
  • DFZ (De Friesland Zorgverzekeraar [Health Insurance Company]) grant for research on perioperative drug management (€120.000)

Awards

  • Best Poster. Waddington F, Naunton M. Physiotherapy students understanding of risks and benefits of NSAIDs: Does year level matter? Australian Physiotherapy Conference, Canberra, 2013.
  • Dutch Society of Hospital Pharmacists [Nederlandse Vereniging van Ziekenhuis Apothekers (NVZA)] Sanofi Aventis Award 2009; best review published by a Dutch hospital pharmacist (awarded to Michiel Duyvendak, PhD candidate supervised by Mark Naunton).
  • Paper: Systematic review of trends in prophylaxis of coticosteroid-induced osteoprosis: the need for standard audit guidelines. Osteoporosis Int. 2008 Oct; 19(10): 1379-94
  • Dutch Society of Pharmacists [Nederlandse Maatschappij ter bevordering van de Pharmacy (KNMP)] Opwijrda Prize; best pharmaceutical care research project published in the journal of the Royal Dutch Pharmacy Society (KNMP; Pharmaceutisch Weekblad, Scientific edition). [awarded to Michiel Duyvendak, supervised by Mark Naunton].
  • Paper. Perioperative drug management: Reduction of potential drug related problems in orthopedic patients undergoing orthopedic surgery by perioperative participation of a hospital pharmacist. Pharm. Weekbl-WP, 2007; 1(5):105-109
    Dean’s Citation Award for Good Teaching (2009), Charles Darwin Univeristy, Northern Territory.
  • Best Presented Paper (2003). Naunton M, Peterson GM, Jones G, Griffin G, Bleasel MD. Multi-faceted Educational Program Increases Prescribing of Preventive Therapy Against Corticosteroid-induced Osteoporosis. Society of Hospital Pharmacists of Australia Conference, March 21-23, 2003, Tasmania, Australia